🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
25.88
-0.32 (-1.22%)
Nov 18, 2026, 1:11 PM EST - Market open

Vera Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
55.32354.7392.6545.6843.4679.67
Short-Term Investments
328.72359.86548.21115.0471.19-
Cash & Short-Term Investments
384.04714.59640.85160.72114.6579.67
Cash Growth
-22.79%11.51%298.75%40.18%43.90%48.26%
Other Receivables
2.593.293.770.51--
Receivables
14.573.293.770.51--
Prepaid Expenses
28.698.475.218.5610.332.38
Other Current Assets
6.912.541.382.240.720.48
Total Current Assets
441.29728.88651.22172.02125.782.54
Property, Plant & Equipment
-3.34.333.045.22-
Long-Term Investments
----0.060.87
Other Long-Term Assets
3.972.550.130.480.460.34
Total Assets
465.75734.73655.68175.55131.4483.75

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
20.1721.97.6711.1211.991.39
Accrued Expenses
31.0829.6414.478.7510.965.93
Current Portion of Leases
-0.551.482.442.65-
Other Current Liabilities
4.531.371.75--0.38
Total Current Liabilities
55.7853.4625.3722.325.67.69
Long-Term Debt
75.4374.8450.6949.8824.814.92
Long-Term Leases
1.361.922.471.43.83-
Other Long-Term Liabilities
---0.290.291.54
Total Liabilities
132.57130.2178.5373.8654.5314.16

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.070.070.060.040.030.02
Additional Paid-In Capital
1,4191,3651,038410.49290.22193.63
Retained Earnings
-1,085-760.87-461.25-309.1-213.11-124.06
Comprehensive Income & Other
-0.70.790.390.25-0.22-
Total Common Equity
333.19604.52577.16101.6976.9169.59
Shareholders' Equity
333.19604.52577.16101.6976.9169.59
Total Liabilities & Equity
465.75734.73655.68175.55131.4483.75

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
76.7977.3154.6453.7131.294.92
Net Cash (Debt)
307.25637.28586.21107.0183.3774.75
Net Cash Growth
-26.88%8.71%447.82%28.36%11.53%39.10%
Net Cash Per Share
4.379.9210.602.513.145.56
Filing Date Shares Outstanding
72.371.3663.7554.4544.2627.05
Total Common Shares Outstanding
72.2971.2763.5644.4527.821.28
Working Capital
385.51675.43625.85149.72100.174.85
Book Value Per Share
4.618.489.082.292.773.27
Tangible Book Value
312.69604.52577.16101.6976.9169.59
Tangible Book Value Per Share
4.338.489.082.292.773.27
SEC Filings: 10-K · 10-Q